CNI Research Ltd. announced that during the board meeting on November 8, 2024, they approved the allotment of 37,800,000 equity shares at Re. 1 each, converting 3,780 optionally convertible debentures (OCDs). This capital raising will involve strategic investors including Seed Factory Pte Limited and Evolution Partners FZC.